News by subject: HEALTH

IntelGenx Corp. (the "Company" or "IntelGenx") today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC ("Xiromed"), has received a Complete Response Letter ("CRL") from the U.S. Food and Drug...

In a release issued under the same headline on Thursday, April 4, 2024 by NeuroVigil, Inc., please note the contact information should be [email protected]. The corrected release follows: Silicon Valley-based Neurotechnology Powerhouse,...

Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBraintm Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of its stock for more than $85 million on Saturday, valuing the company at over $6...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024. Company Fireside Chat Presentation...

The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront...

April 4, 2024  Mom & Baby Mobile Health Centers offering ultrasound screenings to expectant moms in Phoenix, Tucson, and Washington, DC Amsterdam, the Netherlands, and Arlington, VA ? Philips Foundation, with its mission to...

Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a...

Amid mounting pressures and unprecedented challenges across the globe, psychologically safe workplaces have become a necessity for building organizational resilience and sustainable success. Leaders at every level recognize that they need to...

BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce the closing of $1.168 million of convertible...

Arch Biopartners Inc., ("Arch" or the "Company") , announced today that Anesthesia Clinical Trials Unit (ACTU), an academic research organization in the Department of Anesthesia and Pain Management at the University Health Network (UHN), has joined...

Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed...

Autism Speaks Canada marks an evolution in collaborating with and standing alongside the autistic community by launching Autism Speaks Canada's World Autism Month campaign. The campaign includes a pledge to #ActFearlessly for change and the launch of...

PsyCan, the not-for-profit trade association for the legal Canadian psychedelic medicine industry, welcomes the expansion of insurance coverage for psychedelic-assisted therapy (PaT) led by the Alberta Blue Cross. "We welcome Alberta Blue Cross as...

ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company") is proud to announce the official commercial launch of its first-in-class ?Follow-On' formula for infants ages...

Arch Biopartners Inc., ("Arch" or the "Company") , announced today that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's clinical study...

Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial...

Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2023...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...

Nearly 30,000 deaths from noncommunicable diseases in Canada in 2019, were due to high body mass index (BMI), most related to diabetes, cardiovascular disease, and obesity-related cancers. There is extreme urgency for provincial and territorial...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has closed on its agreement with Seyltx Inc. ("Seyltx"), a privately owned U.S. based drug...

With nearly 25 per cent of Canadians becoming seniors by 2030, and a global demographic shift towards an aging population, the need for innovative solutions to improve later life is critical. RTOERO, the trusted voice on healthy, active aging, is...

Markham Fertility Centre (MFC) and humm Canada proudly come together to announce better financing options for patients seeking fertility treatments. Time, cost, and distance can be barriers for patients when accessing fertility care. While the...

York University has long been a leader in health education and research, and we are excited to welcome the Ontario government's newest investment in the future of health care in York Region and beyond, announced today as part of the 2024 Budget:...

LifeLabs, a leading provider of laboratory diagnostic services, is thrilled to introduce our latest offering: At-Home Self-Collection Kits.    LifeLabs' At Home Kit Program provides a diverse range of self-collection kits for various health tests,...

Further to the announcement by Psyence Group Inc ("Psyence" or the "Company") of its plans for the strategic restructuring of its non-clinical business through a conditional M&A transaction (the "Transaction"), Psyence is pleased to announce that...

Yield10 Bioscience, Inc. ("Yield10" or the "Company"), an agricultural bioscience company, today reported that the Plant Biosafety Office ("PBO") of the Canadian Food Inspection Agency ("CFIA") recently reviewed information on the Company's E3902...

Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products across key therapeutic areas, announces that it has signed a...

Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is thrilled to announce it has entered an international MDMA...

Top researchers in the field of type 1 diabetes (T1D) signed an open letter in support of renewed funding for the JDRF-CIHR Partnership to Defeat diabetes through Federal Budget 2024. The letter details the importance of funding research in the...

Hydreight Technologies Inc. ("Hydreight" or the "Company") a mobile clinical network and medical platform which enables flexible, at-home medical services across 50 states in the United States, is pleased to announce that it has partnered with...

77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed by the Epworth Sleepiness Scale (ESS), despite...

AXS-12 statistically significantly reduced cataplexy attacks compared to placebo (p=0.018, primary endpoint) AXS-12 achieved statistically significant remission of cataplexy compared to placebo (p=0.008) AXS-12 statistically significantly reduced...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will phase down its preclinical oncology research...

 March 22, 2024 Amsterdam, the Netherlands ? Royal Philips , today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes....

Rose Hill (or the "Company"), a premium psilocybin cultivator and supplier in Jamaica, announced today a strategic research partnership with the esteemed University of Guelph. This collaboration marks a significant milestone for both entities as they...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced moving to the next...

DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , an artificial intelligence digital healthcare company, announced its application for registration for trademark on its BRAIN AGE® brand has been approved by the Canadian Intellectual Property...

MedBright AI Investments Inc. (the "Company" or "MedBright") today announced Rejuvenation medical group is using the commercial version of MedMatrix AI Reporter for centralized clinic operations reporting and dashboarding. The Company has a...

The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We...

Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue1,2,3,4In China, SPEVIGO®'s expanded approval adds the reduction of...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that the FDA advised the Company to submit a Type...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced the first patient has been dosed in the PARADIGM Phase 3 trial of...

March 19, 2024   Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation,...

British Medical Journal Open publishes paper detailing the results of the international Phase II human trial for LSALT peptide targeting acute lung and kidney inflammation in hospitalized patients infected with SARS-CoV-2 virusPhase II findings...

OBI Pharma, Inc. (TPEx: 4174) today announced preclinical data for OBI-992, a potential best-in-class anti-TROP2 Antibody-Drug Conjugate (ADC). When evaluated against comparative TROP2 ADCs, OBI-992 demonstrated greater antitumor efficacy, superior...

Today, Quantexa, the global leader in Decision Intelligence (DI) solutions for the public and private sectors announced that its Decision Intelligence Platform will be adopted by the University of Liverpool's Civic Health Innovation Labs (CHIL) and...

March 17 ? 23, 2023 is National Impaired Driving Prevention Week. MADD Canada is proud to join governments, law enforcement agencies and community organizations in raising awareness about the risks and consequences of impaired driving with the goal...

Today, as the world marks World Kidney Day, LifeLabs, in exclusive partnership with Klinrisk, proudly announces a groundbreaking advancement in chronic kidney disease (CKD) screening and management: the inclusion of the Klinrisk Score as a validated...

DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , an artificial intelligence digital healthcare company, is pleased to announce it has strengthened support for its intellectual property portfolio by being a client of Intellectual Property...